The direct mechanism by which mAbs induce tumor cell death includes the blockade of growth factor receptor signaling, (anti-EGFR mAbs), or blocking ligand binding and receptor dimerization (anti-EGFR/HER2 heterodimerization and activation) [22]. Here, EGFR is linked to neoplasm.